In order to increase the test’s applicability for cervical cancer screening, self-collected specimens (cohort 3) were used to evaluate the clinical accuracy of TRH methylation, and the results were compared to those of clinician-collected specimens (cohort 4). The gene discussed is TRH; the disease is cervical carcinoma.